首圖

ST. GALLEN, Switzerland -- (BUSINESS WIRE) -- Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Global biotechnology leader CSL Limited (ASX: CSL; USOTC:CSLLY) and Vifor Phar......